These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17557144)

  • 21. AIDS research. Mystery anti-HIV factor unmasked?
    Cohen J
    Science; 2002 Sep; 297(5590):2188. PubMed ID: 12351761
    [No Abstract]   [Full Text] [Related]  

  • 22. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
    Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
    Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals].
    Yuan L; Ma LY; Zang XH; Meng XD; Peng H; Zhao QB; Xing H; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):195-7. PubMed ID: 19031701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.
    Kolber MA
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1002-7. PubMed ID: 15539497
    [No Abstract]   [Full Text] [Related]  

  • 28. [Soluble factors with inhibitory activity against type 1 Human Immunodeficiency Virus].
    Zapata W; Montoya CJ; Rugeles MT
    Biomedica; 2006 Sep; 26(3):451-66. PubMed ID: 17176009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate immune sensing of HIV infection.
    Silvin A; Manel N
    Curr Opin Immunol; 2015 Feb; 32():54-60. PubMed ID: 25617674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do HIV elite controllers do what they do?
    Saag M; Deeks SG
    Clin Infect Dis; 2010 Jul; 51(2):239-41. PubMed ID: 20550453
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tracking down natural resistance to HIV. Defective cellular receptor prevents entrance of virus into the cell].
    Hobom B
    Fortschr Med; 1996 Oct; 114(29):12, 14. PubMed ID: 9005198
    [No Abstract]   [Full Text] [Related]  

  • 32. The search for the CD8+ cell anti-HIV factor (CAF).
    Levy JA
    Trends Immunol; 2003 Dec; 24(12):628-32. PubMed ID: 14644135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting HIV-1 innate immune responses therapeutically.
    Ellegård R; Shankar EM; Larsson M
    Curr Opin HIV AIDS; 2011 Sep; 6(5):435-43. PubMed ID: 21734566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV suppressors found in cells.
    Smart T
    GMHC Treat Issues; 1996 Jan; 10(1):10-2. PubMed ID: 11363373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV pathogenesis: knowledge gained after two decades of research.
    Levy JA
    Adv Dent Res; 2006 Apr; 19(1):10-6. PubMed ID: 16672543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines for HIV--looking to the future.
    TreatmentUpdate; 2004 Oct; 16(6):1-3. PubMed ID: 17219677
    [No Abstract]   [Full Text] [Related]  

  • 37. Plumbing HIV pathogenesis.
    Jefferys R
    Res Initiat Treat Action; 2007; 12(2):36-8. PubMed ID: 17489123
    [No Abstract]   [Full Text] [Related]  

  • 38. Strong ifitm1 Expression in CD4 T Cells in HIV Controllers Is Correlated With Immune Activation.
    Canoui E; Noël N; Lécuroux C; Boufassa F; Sáez-Cirión A; Bourgeois C; Lambotte O;
    J Acquir Immune Defic Syndr; 2017 Feb; 74(2):e56-e59. PubMed ID: 27552157
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanisms of resistance to sexual transmission of HIV-1].
    Eberhard A; Ponceau B; Biron F; Verrier B
    Med Mal Infect; 2005 Nov; 35(11):517-24. PubMed ID: 16253454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms involved in non-progressive HIV disease.
    Mikhail M; Wang B; Saksena NK
    AIDS Rev; 2003; 5(4):230-44. PubMed ID: 15012002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.